iTonic Holdings (ITOC) Total Non-Current Liabilities (2023 - 2025)
iTonic Holdings' (ITOC) quarterly Total Non-Current Liabilities came in at $507015.0 in Q4 2025, up 583.94% quarter-over-quarter from $74132.0 in Q2 2024.
Powered by 
Analysis
iTonic Holdings (ITOC) Total Non-Current Liabilities (2023 - 2025) Analysis & Trends
iTonic Holdings has disclosed Total Non-Current Liabilities across 3 years of filings, most recently posting $507015.0 for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities changed N/A year-over-year to $507015.0; the TTM figure through Dec 2025 stood at $507015.0 (changed N/A YoY), while the FY2025 annual figure was $507015.0, changed N/A from the prior year.
- Total Non-Current Liabilities came in at $507015.0 for Q4 2025 at iTonic Holdings, up from $74132.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $507015.0 in Q4 2025 to a low of $74132.0 in Q2 2024.
- Average Total Non-Current Liabilities over 3 years is $228713.3, with a median of $104993.0 recorded in 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | iTonic Holdings | 4.83 Mn | 1.90 Mn | - | 507,015.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 507,015.00 |
| Jun 30, 2024 | 74,132.00 |
| Dec 31, 2023 | 104,993.00 |